NeuroPace NPCE
NASDAQ NPCE
$14.50 -0.26 (-1.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)

NeuroPace (NPCE) posted Cash from Investing Activities of -$125000.0 for Q2 2026, down 6.84% on a QoQ basis from -$117000.0 in Q1 2026, and up 25.6% year-over-year from -$99526.1 in Q2 2025.

Analysis

NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026) Analysis & Trends

NeuroPace has reported Cash from Investing Activities for 7 years, with the latest figure at -$125000.0 in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 25.6% year-over-year to -$125000.0 in Q2 2026; TTM through Jun 2026 was -$369000.0, a 111.69% decrease from a year earlier, with the FY2025 full-year figure at -$332000.0, down 103.69% from the prior year.
  • Cash from Investing Activities was -$125000.0 for Q2 2026 at NeuroPace, down from -$117000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $10.1 million in Q1 2023, with the low at -$306000.0 in Q1 2022.
  • Average Cash from Investing Activities over 5 years is $3.1 million, with a median of $2.2 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 5877.92% in 2022, then tumbled 216.22% in 2026.
  • Over 5 years, Cash from Investing Activities stood at $8.9 million in 2022, then plunged by 61.02% to $3.5 million in 2023, then plunged by 43.45% to $2.0 million in 2024, then sank by 104.95% to -$97000.0 in 2025, then retreated by 28.87% to -$125000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$125000.0 (Q2 2026), -$117000.0 (Q1 2026), and -$97000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 NeuroPace 493.15 Mn 441.45 Mn 18.91 Mn -125,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -125,000.00
Mar 31, 2026 -117,000.00
Dec 31, 2025 -97,000.00
Sep 30, 2025 -30,000.00
Jun 30, 2025 -168,000.00
Mar 31, 2025 -37,000.00
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 2.40 Mn
Dec 31, 2023 3.47 Mn
Sep 30, 2023 4.19 Mn
Jun 30, 2023 5.30 Mn
Mar 31, 2023 10.07 Mn
Dec 31, 2022 8.90 Mn
Sep 30, 2022 6.97 Mn
Jun 30, 2022 8.24 Mn
Mar 31, 2022 -306,000.00
Dec 31, 2021 -154,000.00
Sep 30, 2021 -190,000.00